There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Kits > Her2 > EHC-V1

ELISA Assay Kit for Anti-HER-2 h-mAb in Monkey Serum

For research use only.
  • Background
    How a therapeutic antibody is metabolized in the body is pertinently relevant to its efficacy. Therefore, pharmacokinetics study is an important part of the drug development. HER-2 is probably the most targeted molecule in today’s pharmaceutical industry, thanking to the clinical success of Herceptin®. Many investigational anti-HER-2 mAbs are being developed. There is a growing need for a standard assay that can be used to facilitate the study of their pharmacokinetics.
  • Application
    It is for research use only.
  • Reconstitution
    See Certificate of Analysis for details of reconstitution instruction and specific concentration.
  • Storage

    Upon receipt, please store all items at -20℃. After reconstitution, the stock solution should be kept at -80℃.

    It is recommended not to freeze thaw more than 3 times.

    This product is stable after storage at: Room temperature (RT) for 1 month in lyophilized state; -20℃ for 1 year in lyophilized state; -80℃ for 4 months under sterile conditions after reconstitution.
  • Assay Principles
    The enclosed ELISA assay kit for anti-HER-2 h-mAb in monkey serum is based on an enzyme immunoassay (ELISA) between recombinant HER-2 protein (ECD) and a biotinylated anti-HER-2 monoclonal antibody. The method employs the principle of competitive ELISA, allowing quantification of monoclonal anti-HER-2 antibodies in monkey serum.

    The assay only involves the following steps:

    1. Coat the plate with human HER-2;

    2. Add the mixture of your sample and biotinylated anti-HER-2 antibody;

    3. Add Streptavidin-HRP followed by TMB or other colorimetric HRP substrate;

    4. Record the OD readings and analyze the serum concentration.

Comments (0)

Order Details

Price(USD) : $1133.00

Promotion & Exhibitions

Drug Development Status

  • Number of Launched Drugs:24 Details
  • Number of Drugs in Clinical Trials:126 Details
  • Latest Research Phase:Approved

Datasheet & Documentation

Request for DMF
DMF (Drug Master File)

Contact Us

+1  800-810-0816 (US)
+86 400-682-2521 (AP)

Related Products

Questions & Comments

This web search service is supported by Google Inc.